Detection of hepatitis B virus covalently closed circular DNA in paraffin-embedded and cryo-preserved liver biopsies of chronic hepatitis B patients

European Journal of Gastroenterology and Hepatology

Volumn 22, Issue 8, 2010, Pages 952-960

  Takkenberg, R Bart ^a   Zaaijer, Hans L ^b   Menting, Sandra ^c   Weegink, Christine J ^a   Terpstra, Valeska ^b   Cornelissen, Marion ^b   Dijkgraaf, Marcel G W ^b   Jansen, Peter L M ^a   Reesink, Hendrik W ^a   Beld, Marcel G H M ^c  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c ROYAL TROPICAL INSTITUTE   (Netherlands)

Author keywords

cccDNA; cryo preserved liver biopsies; hepatitis B; paraffin embedded liver biopsies

Indexed keywords

CIRCULAR DNA; COVALENTLY CLOSED CIRCULAR DNA; EDETIC ACID; FORMALDEHYDE; PARAFFIN; UNCLASSIFIED DRUG; VIRUS DNA; HEPATITIS B(E) ANTIGEN;

ARTICLE; CONTROLLED STUDY; CRYOPRESERVATION; DNA DETERMINATION; DNA EXTRACTION; FOLLOW UP; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER BIOPSY; LIVER CELL; MAJOR CLINICAL STUDY; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; ADULT; BLOOD; COMPARATIVE STUDY; HEPATITIS B, CHRONIC; ISOLATION AND PURIFICATION; LIVER; VIROLOGY;

ADULT; CRYOPRESERVATION; DNA, CIRCULAR; DNA, VIRAL; HEPATITIS B E ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; LIVER; PARAFFIN EMBEDDING;

EID: 77955207859     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e3283376a63     Document Type: Article

References (31)

1. World Health Organization. Hepatitis B. World Health Organization Fact Sheet 204 (Revised August 2008). World Health Organization, 2007.
2. Goldstein ST, Zhou F, Hadler SC, Bell BP, Mast EE, Margolis HS. A mathematical model to estimate global hepatitis B disease burden and vaccination impact. Int J Epidemiol 2005; 34:1329-1339.
3. Seeger C, Mason WS. Hepatitis B virus biology. Microbiol Mol Biol Rev 2000; 64:51-68.
4. Ganem D, Schneider RJ. Hapdnaviridae: the viruses and their replication. In: Knipe DM, Howley PM, editors. Fields virology. 4th edn. Philadelphia: Wolters Kluwer; 2002. pp. 2923-2968. Chapter 29.
5. Tuttleman JS, Pourcel C, Summers J. Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cells. Cell 1986; 47:451-460.
6. Newbold JE, Xin H, Tencza M, Sherman G, Dean J, Bowden S, Locarnini S. The covalently closed duplex form of the hepadnavirus genome exists in situ as a heterogeneous population of viral minichromosomes. J Virol 1995; 69:3350-3357.
7. Werle-Lapostolle B, Bowden S, Locarnini S,Wursthorn K, Petersen J, Lau G, et al. Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy. Gastroenterology 2004; 126:1750-1758.
8. Volz T, Lutgehetmann M, Wachtler P, Jacob A, Quaas A, Murray JM, et al. Impaired intrahepatic hepatitis B virus productivity contributes to low viremia in most HBeAg-negative patients. Gastroenterology 2007; 133:843-852.
9. Laras A, Koskinas J, Dimou E, Kostamena A, Hadziyannis SJ. Intrahepatic levels and replicative activity of covalently closed circular hepatitis B virus DNA in chronically infected patients. Hepatology 2006; 44:694-702.
10. Rehermann B, Ferrari C, Pasquinelli C, Chisari FV. The hepatitis B virus persists for decades after patient's recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response. Nat Med 1996; 2:1104-1108.
11. Mason AL, Xu L, Guo L, Kuhns M, Perrillo RP. Molecular basis for persistent hepatitis B virus infection in the liver after clearance of serum hepatitis B surface antigen. Hepatology 1998; 27:1736-1742.
12. Wong DK, Yuen MF, Ngai VW, Fung J, Lai CL. One-year entecavir or lamivudine therapy results in reduction of hepatitis B virus intrahepatic covalently closed circular DNA levels. Antivir Ther 2006; 11:909-916.
13. Sung JJ, Wong ML, Bowden S, Liew CT, Hui AY, Wong VW, et al. Intrahepatic hepatitis B virus covalently closed circular DNA can be a predictor of sustained response to therapy. Gastroenterology 2005; 128:1890-1897.
14. Wursthorn K, Lutgehetmann M, Dandri M, Volz T, Buggisch P, Zollner B, et al. Peginterferon alpha-2b plus adefovir induce strong cccDNA decline and HBsAg reduction in patients with chronic hepatitis B. Hepatology 2006; 44:675-684.
15. Wong DK, Yuen MF, Yuan H, Sum SS, Hui CK, Hall J, Lai CL. Quantitation of covalently closed circular hepatitis B virus DNA in chronic hepatitis B patients. Hepatology 2004; 40:727-737.
16. Chen Y, Sze J, He ML. HBV cccDNA in patient's sera as an indicator for HBV reactivation and an early signal of liver damage. World J Gastroenterol 2004; 10:82-85.
17. Takkenberg RB, Zaaijer HL, Molenkamp R, Menting S, Terpstra V,Weegink CJ, et al. Validation of a sensitive and specific real-time PCR for detection and quantitation of hepatitis B virus covalently closed circular DNA in plasma of chronic hepatitis B patients. J Med Virol 2009; 81:988-995.
18. Ishak K, Baptista A, Bianchi L, Callea F, De GJ, Gudat F, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995; 22:696-699.
19. European Association For The Study Of The Liver. EASL clinical practice guidelines: management of chronic hepatitis B. J Hepatol 2009; 50:227-242.
20. Boom R, Sol CJ, Heijtink R, Wertheim-van Dillen PM, Van der NJ. Rapid purification of hepatitis B virus DNA from serum. J Clin Microbiol 1991; 29:1804-1811.
21. Boom R, Sol C, Weel J, Gerrits Y, De BM, Wertheim-van DP. A highly sensitive assay for detection and quantitation of human cytomegalovirus DNA in serum and plasma by PCR and electrochemiluminescence. J Clin Microbiol 1999; 37:1489-1497.
22. Bresters D, Cuypers HT, Reesink HW, Chamuleau RA, Schipper ME, Boeser-Nunnink BD, et al. Detection of hepatitis C viral RNA sequences in fresh and paraffin-embedded liver biopsy specimens of non-A, non-B hepatitis patients. J Hepatol 1992; 15:391-395.
23. Saxena R, Zucker SD, Crawford JM. Anatomy and physiology of the liver. In: Zakim D, Boyer TD, editors. Hepatology; a textbook of liver disease. Philidelphia: Elsevier Science; 2003. pp. 3-30.
24. Jackson DP, Lewis FA, Taylor GR, Boylston AW, Quirke P. Tissue extraction of DNA and RNA and analysis by the polymerase chain reaction. J Clin Pathol 1990; 43:499-504.
25. Bourne EJ, Dienstag JL, Lopez VA, Sander TJ, Longlet JM, Hall JG, et al. Quantitative analysis of HBV cccDNA from clinical specimens: correlation with clinical and virological response during antiviral therapy. J Viral Hepat 2007; 14:55-63.
26. Chan HL, Wong VW, Tse AM, Tse CH, Chim AM, Chan HY, et al. Serum hepatitis B surface antigen quantitation can reflect hepatitis B virus in the liver and predict treatment response. Clin Gastroenterol Hepatol 2007; 5:1462-1468.
27. Lupberger J, Hildt E. Hepatitis B virus-induced oncogenesis. World J Gastroenterol 2007; 13:74-81.
28. Lu L, Zhang HY, Yueng YH, Cheung KF, Luk JM, Wang FS, Lau GK. Intracellular levels of hepatitis B virus DNA and pregenomic RNA in peripheral blood mononuclear cells of chronically infected patients. J Viral Hepat 2009; 16:104-112.
29. Stoll-Becker S, Repp R, Glebe D, Schaefer S, Kreuder J, Kann M, et al. Transcription of hepatitis B virus in peripheral blood mononuclear cells from persistently infected patients. J Virol 1997; 71:5399-5407.
30. Cabrerizo M, Bartolome J, Caramelo C, Barril G, Carreno V. Molecular analysis of hepatitis B virus DNA in serum and peripheral blood mononuclear cells from hepatitis B surface antigen-negative cases. Hepatology 2000; 32:116-123.
31. Mazet-Wagner AA, Baclet MC, Loustaud-Ratti V, Denis F, Alain S. Real-time PCR quantitation of hepatitis B virus total DNA and covalently closed circular DNA in peripheral blood mononuclear cells from hepatitis B virusinfected patients. J Virol Methods 2006; 138:70-79.